{"transactions":[{"id":4623829,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":37762,"kind":"person","name":"Young Wendy B.","position":1,"cik":"0002042847","reported_name":"Young Wendy B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-21T23:25:34.000Z","date":"2026-09-17","kind":"grant","planned":false,"acquired":true,"shares":25666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On June 11, 2026, the Issuer's board of directors approved the option grant issued to the Reporting Person on June 12, 2026, which grant was subject to stockholder approval of an amendment to the Issuer's 2017 Equity Incentive Plan to increase the number of shares authorized for issuance thereunder. The Issuer's stockholders approved the plan amendment on September 17, 2026 (\"Stockholder Approval Date\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 11, 2026, the Issuer's board of directors approved the option grant issued to the Reporting Person on June 12, 2026, which grant was subject to stockholder approval of an amendment to the Issuer's 2017 Equity Incentive Plan to increase the number of shares authorized for issuance thereunder. The Issuer's stockholders approved the plan amendment on September 17, 2026 (\"Stockholder Approval Date\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"2,138 shares subject to the stock option vested on the Stockholder Approval Date and the remaining 23,528 shares subject to the stock option shall vest in substantially equal installments over a 33-month period, beginning on October 12, 2026."}],"balance_after":25666,"derivative":{"exercise_price":2.98,"expiration_date":"2036-06-12","underlying":"Common Stock","underlying_shares":25666},"source":{"system":"sec-edgar","filing":"0001213900-26-101883","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042847/000121390026101883/ownership.xml","form_type":"4"}},{"id":736492,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":37762,"kind":"person","name":"Young Wendy B.","position":1,"cik":"0002042847","reported_name":"Young Wendy B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Pre-funded Warrant","published_at":"2026-06-16T10:14:30.000Z","date":"2026-06-12","kind":"purchase","planned":false,"acquired":true,"shares":36378,"price":2.7489,"value":99999.4842,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of that certain Pre-Funded Warrant to Purchase Common Stock, dated June 12, 2026, issued by the Issuer to the Reporting Person pursuant to a securities purchase agreement entered into by and among the Issuer, the Reporting Person and certain other parties on June 11, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The pre-funded warrants to purchase shares of the Issuer's common stock (the \"Pre-Funded Warrants\") have no expiration date and are exercisable at any time after receiving approval of the Issuer's stockholders. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The pre-funded warrants to purchase shares of the Issuer's common stock (the \"Pre-Funded Warrants\") have no expiration date and are exercisable at any time after receiving approval of the Issuer's stockholders. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise."}],"balance_after":36378,"derivative":{"exercise_price":0.001,"underlying":"Common Stock","underlying_shares":36378},"source":{"system":"sec-edgar","filing":"0001213900-26-069021","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042847/000121390026069021/ownership.xml","form_type":"4"}},{"id":743441,"issuer":{"id":4394,"kind":"organization","name":"Rapport Therapeutics, Inc.","symbol":"RAPP"},"owners":[{"id":37762,"kind":"person","name":"Young Wendy B.","position":1,"cik":"0002042847","reported_name":"Young Wendy B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-10T21:24:40.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":15200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest upon the earlier of (i) June 10, 2027 and (ii) the date of the next Annual Meeting of Stockholders of the Issuer, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":15200,"derivative":{"exercise_price":35.21,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":15200},"source":{"system":"sec-edgar","filing":"0001193125-26-266086","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042847/000119312526266086/ownership.xml","form_type":"4"}},{"id":1043063,"issuer":{"id":4394,"kind":"organization","name":"Rapport Therapeutics, Inc.","symbol":"RAPP"},"owners":[{"id":37762,"kind":"person","name":"Young Wendy B.","position":1,"cik":"0002042847","reported_name":"Young Wendy B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-11T22:13:48.000Z","date":"2025-09-11","kind":"purchase","planned":false,"acquired":true,"shares":3500,"price":22.6,"value":79100.0,"ownership":{"direct":true},"balance_after":9500,"source":{"system":"sec-edgar","filing":"0000950170-25-114325","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042847/000095017025114325/ownership.xml","form_type":"4"}},{"id":1106651,"issuer":{"id":4394,"kind":"organization","name":"Rapport Therapeutics, Inc.","symbol":"RAPP"},"owners":[{"id":37762,"kind":"person","name":"Young Wendy B.","position":1,"cik":"0002042847","reported_name":"Young Wendy B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-18T20:15:26.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":10925,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest upon the earlier of (i) June 17, 2026 and (ii) the date of the next Annual Meeting of Stockholders of the Issuer, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":10925,"derivative":{"exercise_price":10.95,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":10925},"source":{"system":"sec-edgar","filing":"0000950170-25-087903","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042847/000095017025087903/ownership.xml","form_type":"4"}},{"id":1208119,"issuer":{"id":4394,"kind":"organization","name":"Rapport Therapeutics, Inc.","symbol":"RAPP"},"owners":[{"id":37762,"kind":"person","name":"Young Wendy B.","position":1,"cik":"0002042847","reported_name":"Young Wendy B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-13T21:00:03.000Z","date":"2025-03-12","kind":"purchase","planned":false,"acquired":true,"shares":6000,"price":10.2083,"value":61249.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $10.20 to $10.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0000950170-25-038855","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042847/000095017025038855/ownership.xml","form_type":"4"}},{"id":1373128,"issuer":{"id":4394,"kind":"organization","name":"Rapport Therapeutics, Inc.","symbol":"RAPP"},"owners":[{"id":37762,"kind":"person","name":"Young Wendy B.","position":1,"cik":"0002042847","reported_name":"Young Wendy B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-08T00:00:42.000Z","date":"2024-11-07","kind":"grant","planned":false,"acquired":true,"shares":29756,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares underlying this option shall vest and become exercisable on November 7, 2025, with the remaining shares vesting in twenty-four (24) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":29756,"derivative":{"exercise_price":26.9,"expiration_date":"2034-11-07","underlying":"Common Stock","underlying_shares":29756},"source":{"system":"sec-edgar","filing":"0000950170-24-123611","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042847/000095017024123611/ownership.xml","form_type":"4"}}]}